Cargando…

Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line

The preparation of a manganese-doped cerium oxide (Mn:CeO(2)) nanocomposite via hydrothermal route is described. Cubic fluorite structure of single phase was exhibited by studying structural analysis through x-ray diffraction (XRD) technique and morphological analysis was conducted by scanning elect...

Descripción completa

Detalles Bibliográficos
Autores principales: Atif, M., Iqbal, Seemab, Fakhar-e-Alam, M., Mansoor, Qaisar, Alimgeer, K.S., Fatehmulla, Amanullah, Hanif, Atif, Yaqub, Nafeesah, Farooq, W.A., Ahmad, Shafiq, Ahmad, Hijaz, Chu, Yu-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878823/
https://www.ncbi.nlm.nih.gov/pubmed/33613052
http://dx.doi.org/10.1016/j.sjbs.2020.12.006
_version_ 1783650401638154240
author Atif, M.
Iqbal, Seemab
Fakhar-e-Alam, M.
Mansoor, Qaisar
Alimgeer, K.S.
Fatehmulla, Amanullah
Hanif, Atif
Yaqub, Nafeesah
Farooq, W.A.
Ahmad, Shafiq
Ahmad, Hijaz
Chu, Yu-ming
author_facet Atif, M.
Iqbal, Seemab
Fakhar-e-Alam, M.
Mansoor, Qaisar
Alimgeer, K.S.
Fatehmulla, Amanullah
Hanif, Atif
Yaqub, Nafeesah
Farooq, W.A.
Ahmad, Shafiq
Ahmad, Hijaz
Chu, Yu-ming
author_sort Atif, M.
collection PubMed
description The preparation of a manganese-doped cerium oxide (Mn:CeO(2)) nanocomposite via hydrothermal route is described. Cubic fluorite structure of single phase was exhibited by studying structural analysis through x-ray diffraction (XRD) technique and morphological analysis was conducted by scanning electron microscope. Surface analytic technique of energy dispersive x-ray spectroscopy (EDX) was conducted to analyze the relative amount of any impurity and doping. Structural changes due to manganese doping such as increment in production of vacancies of oxygen within crystal of cerium oxide, and reduction in size of crystallite and constant of lattice was observed in our research study. Moreover, the Mn:CeO(2) nanocomposite demonstrates differential cytotoxicity against MCF-7 adenocarcinoma cell line, which renders it a promising candidate for targeted cancer therapy. The anti-tumorous activity of the cerium oxide nanocomposite was significantly enhanced with doping of manganese, which is directly linked with the generation of highly reactive oxygen facets. The experimental results are supported by a mathematical model that confirms a confidence level of 95%. This research has paved the way for many utilities in therapeutics and magnetic resonance imaging diagnostics through new observations, and hence verified their math model.
format Online
Article
Text
id pubmed-7878823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78788232021-02-18 Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line Atif, M. Iqbal, Seemab Fakhar-e-Alam, M. Mansoor, Qaisar Alimgeer, K.S. Fatehmulla, Amanullah Hanif, Atif Yaqub, Nafeesah Farooq, W.A. Ahmad, Shafiq Ahmad, Hijaz Chu, Yu-ming Saudi J Biol Sci Original Article The preparation of a manganese-doped cerium oxide (Mn:CeO(2)) nanocomposite via hydrothermal route is described. Cubic fluorite structure of single phase was exhibited by studying structural analysis through x-ray diffraction (XRD) technique and morphological analysis was conducted by scanning electron microscope. Surface analytic technique of energy dispersive x-ray spectroscopy (EDX) was conducted to analyze the relative amount of any impurity and doping. Structural changes due to manganese doping such as increment in production of vacancies of oxygen within crystal of cerium oxide, and reduction in size of crystallite and constant of lattice was observed in our research study. Moreover, the Mn:CeO(2) nanocomposite demonstrates differential cytotoxicity against MCF-7 adenocarcinoma cell line, which renders it a promising candidate for targeted cancer therapy. The anti-tumorous activity of the cerium oxide nanocomposite was significantly enhanced with doping of manganese, which is directly linked with the generation of highly reactive oxygen facets. The experimental results are supported by a mathematical model that confirms a confidence level of 95%. This research has paved the way for many utilities in therapeutics and magnetic resonance imaging diagnostics through new observations, and hence verified their math model. Elsevier 2021-02 2020-12-11 /pmc/articles/PMC7878823/ /pubmed/33613052 http://dx.doi.org/10.1016/j.sjbs.2020.12.006 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Atif, M.
Iqbal, Seemab
Fakhar-e-Alam, M.
Mansoor, Qaisar
Alimgeer, K.S.
Fatehmulla, Amanullah
Hanif, Atif
Yaqub, Nafeesah
Farooq, W.A.
Ahmad, Shafiq
Ahmad, Hijaz
Chu, Yu-ming
Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
title Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
title_full Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
title_fullStr Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
title_full_unstemmed Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
title_short Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
title_sort manganese-doped cerium oxide nanocomposite as a therapeutic agent for mcf-7 adenocarcinoma cell line
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878823/
https://www.ncbi.nlm.nih.gov/pubmed/33613052
http://dx.doi.org/10.1016/j.sjbs.2020.12.006
work_keys_str_mv AT atifm manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT iqbalseemab manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT fakharealamm manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT mansoorqaisar manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT alimgeerks manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT fatehmullaamanullah manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT hanifatif manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT yaqubnafeesah manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT farooqwa manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT ahmadshafiq manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT ahmadhijaz manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline
AT chuyuming manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline